指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

COVID-19大流行期间气管切开术的应用:美国胸科医师学会/美国支气管病与介入肺脏病学会/介入肺脏病项目主任协会专家小组报告

Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors Expert Panel Report.
指南 / 共识 · Chest · 2020-06-06
一句话结论专家组建议对预期需要长期机械通气的COVID-19呼吸衰竭患者行气管切开术,无法推荐具体时机,推荐采用减少气溶胶的技术并加强个人防护。

该共识声明由三个专业学会的专家小组制定,旨在探讨COVID-19大流行期间气管切开术的作用。小组提出关键临床问题,经系统文献综述和改良Delphi共识法,对8个关键问题、14个决策点进行评级,形成8条主要建议和5条补充说明。专家组建议对预期需要长期机械通气的患者行气管切开术,不能推荐具体时机,不建议对确诊COVID-19拟行气管切开的患者常规重复逆转录聚合酶链反应检测,推荐采用减少气溶胶的技术并佩戴增强型个人防护装备以降低医护人员感染风险。

要点

  • 专家组建议对预期需要长期机械通气的COVID-19呼吸衰竭患者行气管切开术。
  • 不能推荐气管切开术的具体时机。
  • 无证据支持对确诊COVID-19拟行气管切开的患者常规重复逆转录聚合酶链反应检测。
  • 为降低医护人员感染风险,推荐采用减少气溶胶的技术并佩戴增强型个人防护装备。
  • 本声明中的建议可能随着大流行期间经验积累而改变。

适用人群与场景

  • COVID-19所致呼吸衰竭患者。

处置流程与药物剂量

  • 专家组建议对预期需要长期机械通气的COVID-19呼吸衰竭患者行气管切开术。
  • 不能推荐气管切开术的具体时机。
  • 不建议对确诊COVID-19拟行气管切开的患者常规重复逆转录聚合酶链反应检测。
  • 推荐采用减少气溶胶的技术行气管切开术,并佩戴增强型个人防护装备,以降低医护人员感染风险。

研究设计与关键结果

  • 来自三个专业学会、代表13家机构的重症医学专家和介入肺脏病专家组成小组,提出针对COVID-19气管切开特定主题的关键临床问题。
  • 应用系统文献综述和改良Delphi共识方法,对8个关键问题对应的14个决策点进行评级,汇总形成8条主要建议和5条补充说明。

证据类型、等级与局限

  • 证据类型:专家小组共识声明(指南/共识)。
  • 方法:系统文献综述和改良Delphi共识法。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对预期需要长期机械通气的COVID-19呼吸衰竭患者,专家组建议行气管切开术。
  • 不能推荐气管切开术的具体时机。
  • 不建议对确诊COVID-19拟行气管切开的患者常规重复逆转录聚合酶链反应检测。
  • 推荐采用减少气溶胶的技术并佩戴增强型个人防护装备行气管切开术,以降低医护人员感染风险。
  • 本声明中的建议可能随着大流行期间经验积累而改变。

指南或共识出处

  • 美国胸科医师学会/美国支气管病与介入肺脏病学会/介入肺脏病项目主任协会专家小组报告:COVID-19大流行期间气管切开术的应用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The role of tracheostomy during the coronavirus disease 2019 (COVID-19) pandemic remains unknown. The goal of this consensus statement is to examine the current evidence for performing tracheostomy in patients with respiratory failure from COVID-19 and offer guidance to physicians on the preparation, timing, and technique while minimizing the risk of infection to health care workers (HCWs).

METHODS: A panel including intensivists and interventional pulmonologists from three professional societies representing 13 institutions with experience in managing patients with COVID-19 across a spectrum of health-care environments developed key clinical questions addressing specific topics on tracheostomy in COVID-19. A systematic review of the literature and an established modified Delphi consensus methodology were applied to provide a reliable evidence-based consensus statement and expert panel report.

RESULTS: Eight key questions, corresponding to 14 decision points, were rated by the panel. The results were aggregated, resulting in eight main recommendations and five additional remarks intended to guide health-care providers in the decision-making process pertinent to tracheostomy in patients with COVID-19-related respiratory failure.

CONCLUSION: This panel suggests performing tracheostomy in patients expected to require prolonged mechanical ventilation. A specific timing of tracheostomy cannot be recommended. There is no evidence for routine repeat reverse transcription polymerase chain reaction testing in patients with confirmed COVID-19 evaluated for tracheostomy. To reduce the risk of infection in HCWs, we recommend performing the procedure using techniques that minimize aerosolization while wearing enhanced personal protective equipment. The recommendations presented in this statement may change as more experience is gained during this pandemic.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Lamb CR, Desai NR, Angel L, et al. Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors Expert Panel Report. Chest. 2020. PMID: 32512006. doi:10.1016/j.chest.2020.05.571

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。